Prevalence and Antimicrobial Susceptibility Pattern of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in the United Arab Emirates
Authors:
- Abiola SenokASAbiola Senok
- Fatima RashidFRFatima Rashid
- Shaikha Mohammed Al-JesmiSAShaikha Mohammed Al-Jesmi
- Debadatta PanigrahiDPDebadatta Panigrahi
- 1 December 2007
- journal article
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 17 (1) , 32-36
Abstract
Objective: To investigate the prevalence and antibiotic susceptibility pattern of extended-spectrum β-lactamases (ESBL)-producing Enterobacteriaecae among patients in the United Arab Emirates. Materials and Methods: A total of 130 Enterobacteriaceaecomprising of Escherichia coli (n = 83), Klebsiella pneumoniae (n = 45) and Klebsiella oxytoca (n = 2) was studied. Of these 130 isolates, 64 were from urine. ESBL screening was by disc diffusion and confirmatory tests for ESBL phenotype were conducted using BD Phoenix™ ESBL System and cephalosporin/clavulanate combination discs. Susceptibility to a panel of antibiotics was evaluated. Results: Of the 130 isolates, 53 (41%) were identified as having ESBL phenotype; of these, 32 (60%) were E. coli, 20 (36%) K. pneumoniae and 2 (4%) K. oxytoca. ESBL phenotype was seen in 100% of endotracheal tubes isolates, 20 (31%) from urine, 7 (58%) from blood and 4 (80%) from catheter tips. Amikacin susceptibility was 100%. Over 90% of ESBL isolates showed resistance to aztreonam and cephalosporins. All Klebsiella isolates were carbapenem sensitive. One ESBL isolate showed intermediate resistance to imipenem and meropenem (both MIC 8 µg/ml), cefotetan (MIC 32 µg/ml) and piperacillin/tazobactam (MIC 32 µg/ml). MIC for the carbapenems was lower in non-ESBL isolates (0.034 µg/ml) than ESBL isolates (0.071 µg/ml). Resistance to gentamicin, ciprofloxacin and piperacillin/tazobactam was higher in ESBL than non-ESBL isolates (p < 0.05). Conclusion: A high prevalence of ESBL-producing bacteria exists among in-patients in the United Arab Emirates. Amikacin and carbapenems remain the most effective drugs, but the presence of carbapenem-resistant ESBL-producing E. coli and occurrence of multidrug resistance are of concern. Continued surveillance and judicious antibiotic usage are recommended.Keywords
This publication has 22 references indexed in Scilit:
- CTX-M-Type Extended-Spectrum β-Lactamases in Italy: Molecular Epidemiology of an Emerging Countrywide ProblemAntimicrobial Agents and Chemotherapy, 2006
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Prevalence of Extended-Spectrum Beta-Lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as Determined by the VITEK 2 and E Test Systems in a Kuwait Teaching HospitalMedical Principles and Practice, 2005
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- An Outbreak of Extended-Spectrum β-Lactamase-ProducingKlebsiellaSpecies in a Neonatal Intensive Care Unit in BrazilInfection Control & Hospital Epidemiology, 2002
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Epidemiology of Ciprofloxacin Resistance and Its Relationship to Extended-Spectrum -Lactamase Production in Klebsiella pneumoniae Isolates Causing BacteremiaClinical Infectious Diseases, 2000
- In vitro evaluation of cefepime and other broad-spectrum β-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samplesDiagnostic Microbiology and Infectious Disease, 1999
- Multicenter evaluation of the antimicrobial activity for six broad-spectrum β-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest methodDiagnostic Microbiology and Infectious Disease, 1999
- Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescensInfection, 1983